The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...
Medera announced that updated results from its ongoing MUSIC-HFpEF Phase 1/2a clinical trial investigating SRD-002, a one-time gene therapy ...
Liberal fluid intake was safe and suggestive of better health status: this should be enough to stop restricting patients to 1 ...
The following is a summary of "Role Of Cut-Off Values For Creatinine, Blood Urea Nitrogen, And Uric Acid In Prognostic ...
The largest randomized study of fluid intake restrictions showed no benefit from the restrictions, according to its senior ...
Despite the randomized trial showing a difference in outcomes, more data are needed before changing practice, says one expert ...
The therapeutic approach was safe, but the study did not meet its primary efficacy outcome using the six-minute walking test.
A gene therapy for heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, has shown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback